Literature DB >> 12857985

Melanosomes and MHC class II antigen-processing compartments: a tinted view of intracellular trafficking and immunity.

Michael S Marks1, Alexander C Theos, Graça Raposo.   

Abstract

Melanosomes are specialized intracellular compartments within melanocytes and retinal pigment epithelial cells that function in the synthesis, storage, and secretion of melanins, which are the major pigments made by mammals. The mechanisms that regulate the formation of melanosomes, and the pathways by which constituent proteins are targeted to them, are related to those involved in the biogenesis of major histocompatibility complex (MHC) class II antigen-processing compartments. Consequently, diseases that affect pigmentation may also affect antigen presentation to T cells. Moreover, many of the tissue-specific proteins that localize to melanosomes and participate in melanin formation double as tumor-associated antigens that are targets for T cells in patients with melanoma. Our studies on melanosome biogenesis are providing new ways of thinking about antigen-processing compartments and the mechanisms regulating presentation of tumor-associated antigens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857985     DOI: 10.1385/IR:27:2-3:409

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  112 in total

1.  The leucine-based sorting motifs in the cytoplasmic domain of the invariant chain are recognized by the clathrin adaptors AP1 and AP2 and their medium chains.

Authors:  M W Hofmann; S Höning; D Rodionov; B Dobberstein; K von Figura; O Bakke
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

Review 2.  Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation.

Authors:  J Reimann; R Schirmbeck
Journal:  Immunol Rev       Date:  1999-12       Impact factor: 12.988

3.  Pmel17 initiates premelanosome morphogenesis within multivesicular bodies.

Authors:  J F Berson; D C Harper; D Tenza; G Raposo; M S Marks
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

Review 4.  Antigen processing for amateurs and professionals.

Authors:  I Mellman; S J Turley; R M Steinman
Journal:  Trends Cell Biol       Date:  1998-06       Impact factor: 20.808

5.  Di-leucine signals mediate targeting of tyrosinase and synaptotagmin to synaptic-like microvesicles within PC12 cells.

Authors:  A D Blagoveshchenskaya; E W Hewitt; D F Cutler
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

Review 6.  Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome.

Authors:  W Introne; R E Boissy; W A Gahl
Journal:  Mol Genet Metab       Date:  1999-10       Impact factor: 4.797

Review 7.  The use of melanosomal proteins in the immunotherapy of melanoma.

Authors:  Y Kawakami; P F Robbins; R F Wang; M Parkhurst; X Kang; S A Rosenberg
Journal:  J Immunother       Date:  1998-07       Impact factor: 4.456

8.  Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells.

Authors:  L Li; S N Cohen
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

9.  The AP-3-dependent targeting of the melanosomal glycoprotein QNR-71 requires a di-leucine-based sorting signal.

Authors:  R Le Borgne; N Planque; P Martin; F Dewitte; S Saule; B Hoflack
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

10.  Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells.

Authors:  G Raposo; D Tenza; D M Murphy; J F Berson; M S Marks
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

View more
  3 in total

1.  Processing of tumor antigen differentially impacts the development of helper and effector CD4+ T-cell responses.

Authors:  Dannie Bernard; Michael S Ventresca; Laura A Marshall; Carole Evelegh; Yonghong Wan; Jonathan L Bramson
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

2.  Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.

Authors:  Oliver G Goldstein; Laela M Hajiaghamohseni; Shereen Amria; Kumaran Sundaram; Sakamuri V Reddy; Azizul Haque
Journal:  Cancer Immunol Immunother       Date:  2008-03-15       Impact factor: 6.968

Review 3.  A central role for inducible heat-shock protein 70 in autoimmune vitiligo.

Authors:  Jeffrey A Mosenson; Jonathan M Eby; Claudia Hernandez; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2013-06-20       Impact factor: 3.960

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.